VCG
Vantage Consulting Group’s ADC Therapeutics ADCT Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.83M | Sell |
682,998
-167,739
| -20% | -$450K | 31.92% | 2 |
|
|
2025
Q1 | $1.2M | Hold |
850,737
| – | – | 23.88% | 3 |
|
|
2024
Q4 | $1.69M | Hold |
850,737
| – | – | 16.14% | 3 |
|
|
2024
Q3 | $2.68M | Hold |
850,737
| – | – | 23.47% | 3 |
|
|
2024
Q2 | $2.69M | Hold |
850,737
| – | – | 2% | 6 |
|
|
2024
Q1 | $3.82M | Hold |
850,737
| – | – | 2.43% | 4 |
|
|
2023
Q4 | $1.41M | Hold |
850,737
| – | – | 0.95% | 7 |
|
|
2023
Q3 | $763K | Sell |
850,737
-34,783
| -4% | -$31.2K | 0.51% | 7 |
|
|
2023
Q2 | $1.9M | Sell |
885,520
-300,695
| -25% | -$646K | 1.1% | 7 |
|
|
2023
Q1 | $2.31M | Hold |
1,186,215
| – | – | 1.31% | 6 |
|
|
2022
Q4 | $4.56M | Hold |
1,186,215
| – | – | 2.69% | 5 |
|
|
2022
Q3 | $5.72M | Hold |
1,186,215
| – | – | 3.34% | 4 |
|
|
2022
Q2 | $9.43M | Sell |
1,186,215
-493,934
| -29% | -$3.93M | 5.29% | 3 |
|
|
2022
Q1 | $24.7M | Hold |
1,680,149
| – | – | 9.63% | 3 |
|
|
2021
Q4 | $33.9M | Hold |
1,680,149
| – | – | 9.12% | 3 |
|
|
2021
Q3 | $45.6M | Hold |
1,680,149
| – | – | 9.77% | 3 |
|
|
2021
Q2 | $40.9M | Hold |
1,680,149
| – | – | 7.12% | 3 |
|
|
2021
Q1 | $41M | Hold |
1,680,149
| – | – | 8.23% | 2 |
|
|
2020
Q4 | $53.8M | Buy |
+1,680,149
| New | +$53.8M | 4.38% | 2 |
|